Citation, commencement and interpretation

1.—(1) This order may be cited as the Medicines (Cyanogenetic Substances) Order 1984 and shall come into operation on the tenth day after the day on which it is made.

(2) In this order—

“the Act” means the Medicines Act 1968;

“cyanogenetic substances” means preparations which—

Application of specified provisions of the Act

2.  For the purposes of section 104(1) of the Act, cyanogenetic substances which are intended for human consumption and are not manufactured, sold, supplied, imported or exported wholly or mainly in either of the ways specified in section 130(1) of the Act are hereby specified as substances which appear to the Health Ministers to be substances which are not medicinal products but which are manufactured, sold, supplied, imported or exported for use wholly or partly for a medicinal purpose and it is hereby directed that the provisions contained in Part I, sections 51, 52, 55(1), 57, 58, 61 to 67, 85 to 88, 91 to 93, 95 and 97 and Part VIII of the Act shall have effect in relation to such substances as those provisions have effect in relation to medicinal products.

EXPLANATORY NOTE

This Order extends the application of those provisions of the Medicines Act 1968 specified in Article 2 of the Order to preparations which are not medicinal products but are either presented for sale or supply as, or as containing, amygdalin, laetrile or vitamin B17 or contain the cyanide-producing substances mentioned in Article 1(2)(b) of the Order. The provisions which are so applied relate to the administration of the Act, dealings with products (including sale, supply and importation), the packaging and promotion of products, criminal offences created to enforce those provisions, and miscellaneous and supplementary provisions. Part II of that Act relating to the licensing of products is not applied.